Table 4.
Day | X2 | EB3 | SEM | P-value | ||||
---|---|---|---|---|---|---|---|---|
- | + | - | + | X | EB | X × EB | ||
0 | 6.50 | 6.47 | 6.44 | 6.53 | 0.21 | 0.888 | 0.645 | 0.890 |
7 | 7.95 | 7.97 | 7.83 | 8.09 | 0.20 | 0.892 | 0.209 | 0.581 |
14 | 11.60 | 11.65 | 11.43 | 11.82 | 0.20 | 0.774 | 0.063 | 0.448 |
21 | 15.47 | 15.51 | 15.26 | 15.72 | 0.21 | 0.861 | 0.027 | 0.350 |
28 | 19.88 | 19.95 | 19.59 | 20.24 | 0.21 | 0.749 | 0.002 | 0.404 |
1 n = 24 pens per treatment (main effects); data were analyzed using repeated measurements; week was significant (P < 0.05), and no X × EB × Week interaction (P > 0.10).
2Xylanase activity was expected to be 15,000 EPU/g and inclusion rate was 0.01% according to the manufacturer’s recommendation.
3One gram EB was expected to contain 7,000 CU of cellulase, 5,000 U of β-glucanase, and 1,000 EPU of xylanase; the inclusion rate of EB was 0.01% according to the manufacturer’s recommendation.